More importantly, the results presented herein prove that vitamin B12 downregulates CCL3 in leukocytes of patients with moderate or severe COVID-19 via the hypermethylation of CpGs and subsequent inhibition of TF binding to the analyzed regulatory region. This evidence concerns the gene TF and COVID-19.